- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 215
IsoPlexis applies itself to IPO filing
Yale University is in line to exit proteomics platform developer IsoPlexis in a Nasdaq Global Market offering with a $100m placeholder target.
Jul 23, 2021Couchbase sits pretty in $200m IPO
Docomo Capital-backed database software provider Couchbase floated above its range in an offering following some $250m in venture funding.
Jul 23, 2021ArcelorMittal helps Form Energy recharge in $200m round
ArcelorMittal led the rechargeable battery developer's series D round with a $25m investment through its XCarb vehicle.
Jul 23, 2021FloQast counts on Coupa in $110m round
Coupa’s recently launched venture capital fund has contributed to a series D round for FloQast that valued the accounting software provider at $1.2bn.
Jul 23, 2021Sundae sucks in $80m
First American Financial invested in the repossession real estate marketplace through a series C round increasing its overall funding to more than $132m.
Jul 23, 2021Daily Deal Round Up: July 22, 2021
Several corporates backed a $68m series D round for microbiome drug developer Vedanta Biosciences while grooming brand owner Pangaea raised the same amount from investors including Unilever.
Jul 22, 2021SmartRecruiters secures $110m in series E funding
The Salesforce-backed recruitment managemeent software provider was valued at $1.5bn in a round that pushed its overall funding past $200m.
Jul 22, 2021TMRW taps GV for $105m series C
TMRW Life Sciences is eyeing a global expansion of its frozen egg and embryo management services with new capital from investors including GV.
Jul 22, 2021OpenSea captures $100m at $1.5bn valuation
The NFT marketplace, which counts Coinbase, Animoca Brands and Gumi as investors, raised the funding in a series B round led by Andreessen Horowitz.
Jul 22, 2021IsoPlexis applies itself to IPO filing
Danaher is in line to exit proteomics platform developer IsoPlexis in a Nasdaq Global Market offering with a $100m placeholder target.
Jul 22, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


